The newest guidelines for testing, managing, and treating hepatic C infections in adults are part of a “living document” – a constantly updated online resource that reflects the ever-changing world...
WASHINGTON – Almost 40% of men with inflammatory bowel disease said the disease had a negative effect on their libido and almost 30% said that the disease had prevented them from having sex, in a...
WASHINGTON – Treatment with an oral formulation of budesonide was associated with significant improvements in dysphagia and esophageal eosinophil counts in adolescents and adults with eosinophilic...
WASHINGTON – An investigational once-daily antiviral drug combination produced high rates of sustained viral responses after 12 or 16 weeks of therapy – with or without ribavirin – in patients with...
In an average-risk population, screening colonoscopies yield different incidences of colorectal cancer and different cancer-related mortality, depending on the operators’ adenoma detection rates,...
Antibiotic therapy failed to be shown as noninferior to surgery in a study of adults with uncomplicated acute appendicitis, but it did resolve the problem and avert surgery with no adverse effects in...
PHILADELPHIA – Drug-induced liver injury (DILI) continues to be a hot topic, but new advances have helped increase the amount of research done and improve the quality of treatment for patients...
PHILADELPHIA – The topic of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) was discussed at length by Dr. Zobair M. Younossi, a physician with the Inova Health...
Washington – When it’s given early in the course of treatment for patients who have acute pancreatitis and biliary obstruction without cholangitis, endoscopic retrograde cholangiopancreatography...
PHILADELPHIA – The treatment of patients with hepatic encephalopathy is still plagued by confusion, misdiagnosis, and poor treatment, and requires new protocols to improve overall patient care....
